Reyoung Pharm.

Country/Region: China

Main Products: Penicillin Cephalosporin Cardio Cerebral Vascular Drugs API, Penicillin Cephalosporin Cardio Cerebral Vascular Drugs API

Company Introduction
Our Cephalosporines goes through a top-notch quality analysis system supervised by skilled quality auditors who assess different products at different level. We have developed a state-of-the-art facility located in Zibo, Shandong, China, laced with all the required amenities to keep the Cephalosporines quality consistent and maintained. Buyers can reach us for acquiring first in class Penicillin Cephalosporin Cardio cerebral vascular drugs API, as we are enlisted among best in class Manufacturers since 2009.Entire product line from reyoung pharm. Pvt Ltd are made available in different variations with quality commitments that has no match, making our Cephalosporines and Penicillin Cephalosporin Cardio cerebral vascular drugs API highly demanded in the international market. Owing to which our export ratio value has reached US$50 Million - US$100 Million based on Australia,Canada,Germany,South Korea,Poland market share. Being a quality-conscious entity and a leading Exporter of Cephalosporines, we make sure that all our products perfectly comply with the laid industry standards and boast supreme quality. This approach throughout our 11 Years of export history led us to acquire Approx 5 Million US Dollar of yearly output.Our professional enterprise was first launched with US$50 Million - US$100 Million of initial investment under Own Lisence.
Company Overview

Business Type: Manufacturer

Business Nature: Manufacturer

Year Established: 2009, 2009

Legal Status: Own Lisence

Ownership: Pvt Ltd

Employees: 501 - 1000 People

Factory Size: 30, 000-50, 000 square meters

R&D Team Size: 5 - 10 People

Certifications: GSV

Contact Information

Contact Person: Hugor Hao

Designation: Purchasing

Department: Industrial designer

Telephone: 86-3257850

Business Information

Main Markets: Germany (28%) South Korea (28%) Poland (28%) Australia (14%) Canada (13%)

Export Focus: Australia, Canada, Germany, South Korea, Poland

Contract Services: Buyer Label Offered

Trade & Financial Information

Annual Revenue: Approx 5 Million US Dollar

Registered Capital: US$50 Million - US$100 Million

Export Percentage: 71% - 80%

Payment Terms: Bank wire (T/T), Doc Against Acceptance (D/A), MoneyGram, Cash

Product Showcase
Penicillin Cephalosporin Cardio cerebral vascular drugs API
Penicillin Cephalosporin Cardio cerebral vascular drugs API

CL-Link > Health & Medicines in China Medicines in China Cephalosporines in China